Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Rimassa, Lorenza; Woerns, Marcus-Alexander
Navigating the new landscape of second-line treatment in advanced hepatocellular carcinomaLIVER INTERNATIONAL. Bd. 40. H. 8. 2020 S. 1800-1811
Fontana, Elisa; Zichi, Clizia; Smyth, Elizabeth Catherine et al.
Neoadjuvant chemoradiation (CRT) for locally advanced rectal cancer (LARC) with or without oxaliplatin (OX): Individual patient data (IPD) meta-analysis of three randomized controlled trials (RCTs) with subgroup analyses of age cohorts.JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 15. 2020
Koensgen, Dominique; Battista, Marco J.; Egger, Eva Katharina et al.
New therapeutic approaches in recurrent cervical cancerONKOLOGE. Bd. 26. H. 7. 2020 S. 623-629
Kaps, Leonard; Labenz, Christian; Galle, Peter R. et al.
Non-alcoholic fatty liver disease increases the risk of incident chronic kidney diseaseUNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2020
Labenz, Christian; Huber, Yvonne; Michel, Maurice et al.
Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and DepressionHEPATOLOGY COMMUNICATIONS. 2020
Zebralla, Veit; Mueller, Juliane; Wald, Theresa et al.
Obtaining Patient-Reported Outcomes Electronically With "OncoFunction" in Head and Neck Cancer Patients During AftercareFRONTIERS IN ONCOLOGY. Bd. 10. 2020
Bostel, T.; Mattke, M.; Nicolay, N. H. et al.
Oncological Long-term data on Carbon-based Radiotherapy of primary and recurrent sacral ChordomasSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 196. H. SUPPL 1. 2020 S. S60-S60
Rosentreter, J; Engl, A.-K.; Wojnowski, L et al.
Optimierung des Interaktionsmanagements zur Prävention potenzieller schwerwiegender Arzneimittelinteraktionen bei onkologischen Patientenbest practice onkologie. 2020 S. elektronisch
Boeckers, Madeleine; Paul, Norbert W.; Efferth, Thomas
Organophosphate ester tri-o-cresyl phosphate interacts with estrogen receptor alpha in MCF-7 breast cancer cells promoting cancer growthTOXICOLOGY AND APPLIED PHARMACOLOGY. Bd. 395. 2020
Finn, Richard S.; Boer, Katalin; Bondarenko, Igor et al.
Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2-advanced breast cancer (PALOMA-1, TRIO-18)BREAST CANCER RESEARCH AND TREATMENT. Bd. 183. H. 2. 2020 S. 419-428